The Effect of Sodium Bicarbonate Upon Urinary Citrate Excretion in Calcium Stone Formers


      To evaluate the effects of oral sodium bicarbonate (NaBic) supplementation upon urinary citrate excretion in calcium stone formers (CSFs).


      Sixteen adult calcium stone formers with hypocitraturia were enrolled in a randomized, double-blind, crossover protocol using 60 mEq/day of NaBic during 3 days compared to the same period and doses of potassium citrate (KCit) supplementation. Blood and 24-hour urine samples were collected at baseline and during the third day of each alkali salt.


      NaBic, similarly to KCit supplementation, led to an equivalent and significant increase in urinary citrate and pH. Compared to baseline, NaBic led to a significant increase in sodium excretion without concomitant increases in urinary calcium excretion, whereas KCit induced a significant increase in potassium excretion coupled with a significant reduction in urinary calcium. Although NaBic and KCit both reduced calcium oxalate supersaturation (CaOxSS) significantly vs baseline, KCit reduced calcium oxalate supersaturation significantly further vs NaBic. Both KCit and NaBic significantly reduced urinary phosphate and increased calcium phosphate supersaturation (CaPSS) compared to baseline. Finally, a significantly higher sodium urate supersaturation (NaUrSS) was observed after the use of the 2 drugs.


      This short-term study suggests that NaBic represents an effective alternative for the treatment of hypocitraturic calcium oxalate stone formers who cannot tolerate or afford the cost of KCit. In view of the increased sodium urate supersaturation, patients with pure uric acid stones and high urate excretion may be less suited for treatment with NaBic.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Urology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Levy F.L.
        • Adams-Huet B.
        • Pak C.Y.
        Ambulatory evaluation of nephrolithiasis: an update of a 1980 protocol.
        Am J Med. 1995; 98: 50-59
        • Heilberg I.P.
        • Schor N.
        Renal stone disease: causes, evaluation and medical treatment.
        Arq Bras Endocrinol Metabol. 2006; 50: 823-831
        • Zuckerman J.M.
        • Assimos D.G.
        Hypocitraturia: pathophysiology and medical management.
        Rev Urol. 2009; 11: 134-144
        • Martini L.A.
        • Cuppari L.
        • Cunha M.A.
        • et al.
        Potassium and sodium intake and excretion in calcium stone forming patients.
        J Ren Nutr. 1998; 8: 127-131
        • Taylor E.N.
        • Stampfer M.J.
        • Mount D.B.
        • et al.
        DASH-style diet and 24-hour urine composition.
        Clin J Am Soc Nephrol. 2010; 5: 2315-2322
        • Baia L da C.
        • Baxmann A.C.
        • Moreira S.R.
        • et al.
        Noncitrus alkaline fruit: a dietary alternative for the treatment of hypocitraturic stone formers.
        J Endourol. 2012; 26: 1221-1226
        • Caudarella R.
        • Rizzoli E.
        • Buffa A.
        • et al.
        Comparative study of the influence of 3 types of mineral water in patients with idiopathic calcium lithiasis.
        J Urol. 1998; 159: 658-663
        • Karagülle O.
        • Smorag U.
        • Candir F.
        • et al.
        Clinical study on the effect of mineral waters containing bicarbonate on the risk of urinary stone formation in patients with multiple episodes of CaOx-urolithiasis.
        World J Urol. 2007; 25: 315-323
        • Robinson M.R.
        • Leitao V.A.
        • Haleblian G.E.
        • et al.
        Impact of long-term potassium citrate therapy on urinary profiles and recurrent stone formation.
        J Urol. 2009; 181: 1145-1150
        • Ettinger B.
        • Pak C.Y.
        • Citron J.T.
        • et al.
        Potassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis.
        J Urol. 1997; 158: 2069-2073
        • Sakhaee K.
        • Nicar M.
        • Hill K.
        • Pak C.Y.
        Contrasting effects of potassium citrate and sodium citrate therapies on urinary chemistries and crystallization of stone-forming salts.
        Kidney Int. 1983; 24: 348-352
        • Mattle D.
        • Hess B.
        Preventive treatment of nephrolithiasis with alkali citrate--a critical review.
        Urol Res. 2005; 33: 73-79
        • Tiselius H.G.
        Risk formulas in calcium oxalate urolithiasis.
        World J Urol. 1997; 15: 176-185
        • Tiselius H.G.
        A simplified estimate of ion-activity product of calcium phosphate in urine.
        Eur Urol. 1984; 10: 191-195
        • Tiselius H.G.
        Kidney stones: medical and surgical management.
        Lippincott-Raven Publishers, Philadelphia1996 (33-64)
        • Demigné C.
        • Sabboh H.
        • Puel C.
        • et al.
        Organic anions and potassium salts in nutrition and metabolism.
        Nutr Res Rev. 2004; 17: 249-258
        • Sakhaee K.
        • Alpern R.
        • Jacobson H.R.
        • Pak C.Y.
        Contrasting effects of various potassium salts on renal citrate excretion.
        J Clin Endocrinol Metab. 1991; 72: 396-400
        • Fjellstedt E.
        • Denneberg T.
        • Jeppsson J.O.
        • Tiselius H.G.
        A comparison of the effects of potassium citrate and sodium bicarbonate in the alkalinization of urine in homozygous cystinuria.
        Urol Res. 2001; 29: 295-302
        • Lemann Jr., J.
        • Gray R.W.
        • Pleuss J.A.
        Potassium bicarbonate, but not sodium bicarbonate, reduces urinary calcium excretion and improves calcium balance in healthy men.
        Kidney Int. 1989; 35: 688-695
        • Lemann Jr., J.
        • Pleuss J.A.
        • Gray R.W.
        • Hoffmann R.G.
        Potassium administration reduces and potassium deprivation increases urinary calcium excretion in healthy adults [corrected].
        Kidney Int. 1991; 39: 973-983
        • Dawson-Hughes B.
        • Harris S.S.
        • Palermo N.J.
        • et al.
        Treatment with potassium bicarbonate lowers calcium excretion and bone resorption in older men and women.
        J Clin Endocrinol Metab. 2009; 94: 96-102
        • Moe O.W.
        • Pearle M.S.
        • Sakhaee K.
        Pharmacotherapy of urolithiasis: evidence from clinical trials.
        Kidney Int. 2011; 79: 385-392
        • Soygür T.
        • Akbay A.
        • Küpeli S.
        Effect of potassium citrate therapy on stone recurrence and residual fragments after shockwave lithotripsy in lower caliceal calcium oxalate urolithiasis: a randomized controlled trial.
        J Endourol. 2002; 16: 149-152
        • Hofbauer J.
        • Höbarth K.
        • Szabo N.
        • Marberger M.
        Alkali citrate prophylaxis in idiopathic recurrent calcium oxalate urolithiasis--a prospective randomized study.
        Br J Urol. 1994; 73: 362-365
        • Barcelo P.
        • Wuhl O.
        • Servitge E.
        • et al.
        Randomized double-blind study of potassium citrate in idiopathic hypocitraturic calcium nephrolithiasis.
        J Urol. 1993; 150: 1761-1764